Next-Generation Eye Treatment OLN324 Demonstrates Superior Performance in Major Clinical Trial

Ollin Biosciences has announced important clinical trial results showing that OLN324, an investigational eye treatment, outperforms an existing therapy in treating two serious retinal diseases that threaten vision in millions…

Continue Reading Next-Generation Eye Treatment OLN324 Demonstrates Superior Performance in Major Clinical Trial
Georgia Retina Performs First Susvimo Implantation in State for Wet Macular Degeneration
source: pixabay.com

Georgia Retina Performs First Susvimo Implantation in State for Wet Macular Degeneration

In October 2021, the FDA approved Susvimo (ranibizumab injection) for the treatment of wet age-related macular degeneration. Now, shares WFMZ, Dr. Chin Yee from Georgia Retina has performed the first…

Continue Reading Georgia Retina Performs First Susvimo Implantation in State for Wet Macular Degeneration